18

The IVth Congress of the Romanian Society of Bone Marrow ... › wp-content › ...cunoaste dacä daratumumab este excretat în aptele uman sau a imal. gG materne se excretä în laptele

Download PDF Report

Upload
others
View
3
Download
0

Embed Size (px)

Citation preview

•

•

•

•
Acest mesaj promoțional este destinat profesioniștilor din domeniul sănățății

C-APROM/RO/ADCE/0010 November 2020
β

Do you have patients on Daratumumab who need to be tested ...Multiple Myeloma, Daratumumab-Specific, Immunofixation test helps multiple myeloma patients treated with daratumumab to

Do you have patients on Daratumumab who need to be tested ...Multiple Myeloma, Daratumumab-Specific, Immunofixation test helps multiple myeloma patients treated with daratumumab to

Documents

5 Genmab-blockbuster på markedet inden årsskiftetflashnews.ugebrev.dk/download/Oekonomisk_Ugebrev_NBP_4_2015.pdf · med en injicerbar/subkutan version af Daratumumab, hvilket potentielt

5 Genmab-blockbuster på markedet inden årsskiftetflashnews.ugebrev.dk/download/Oekonomisk_Ugebrev_NBP_4_2015.pdf · med en injicerbar/subkutan version af Daratumumab, hvilket potentielt

Documents

Janssen Research & Development Statistical Analysis Plan … · 2019-09-24 · DPS data presentation specification DRd Daratumumab, lenalidomide, dexamethasone ECG electrocardiogram

Janssen Research & Development Statistical Analysis Plan … · 2019-09-24 · DPS data presentation specification DRd Daratumumab, lenalidomide, dexamethasone ECG electrocardiogram

Documents

ANEXĂ (Anexa la Hotărârea Guvernului nr. ) F APTELE pentru ... · 1 ANEXĂ (Anexa la Hot

ANEXĂ (Anexa la Hotărârea Guvernului nr. ) F APTELE pentru ... · 1 ANEXĂ (Anexa la Hot

Documents

Darzalex, INN-daratumumab

Darzalex, INN-daratumumab

Documents

Targeting CD38 with Daratumumab Monotherapy in Multiple ...Multiple myeloma cells uniformly overexpress CD38. We studied daratumumab, a CD38-targeting, human IgG1κ monoclonal antibody,

Targeting CD38 with Daratumumab Monotherapy in Multiple ...Multiple myeloma cells uniformly overexpress CD38. We studied daratumumab, a CD38-targeting, human IgG1κ monoclonal antibody,

Documents

Daratumumab in Combination With Carfilzomib and

Daratumumab in Combination With Carfilzomib and

Documents

DARZALEX DARATUMUMAB 100 mg/5 ml y 400 … de aprobación: 30-Nov-2017 AR_DARA_INJ_Phl-Pal_EUPI Apr-17_V.3+D-2017-007_A_es Página 1 de 27 DARZALEX® DARATUMUMAB 100 mg/5 ml y 400

DARZALEX DARATUMUMAB 100 mg/5 ml y 400 … de aprobación: 30-Nov-2017 AR_DARA_INJ_Phl-Pal_EUPI Apr-17_V.3+D-2017-007_A_es Página 1 de 27 DARZALEX® DARATUMUMAB 100 mg/5 ml y 400

Documents

oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/... · Cycle 2 Cvcle3-6 Cycle7-24 Follow-Up Daratumumab infusions (First infusion includes pre-dose the before) Lenalidomide

oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/... · Cycle 2 Cvcle3-6 Cycle7-24 Follow-Up Daratumumab infusions (First infusion includes pre-dose the before) Lenalidomide

Documents

multiple myeloma & daratumumab

multiple myeloma & daratumumab

Health & Medicine

Split First Dose Administration of Intravenous Daratumumab ... · subsequent intravenous infusions of daratu-mumab were 7.0, 4.3, and 3.4 h, respectively. Splitting the ﬁrst intravenous

Split First Dose Administration of Intravenous Daratumumab ... · subsequent intravenous infusions of daratu-mumab were 7.0, 4.3, and 3.4 h, respectively. Splitting the ﬁrst intravenous

Documents

Original Article Anti-CD38 Therapy with Daratumumab for

Original Article Anti-CD38 Therapy with Daratumumab for

Documents

Subcutaneous daratumumab in Asian patients with heavily

Subcutaneous daratumumab in Asian patients with heavily

Documents

Effect of Bortezomib Regimens and Daratumumab Monotherapy

Effect of Bortezomib Regimens and Daratumumab Monotherapy

Documents

ANEXĂ (Anexa la Hotărârea Guvernului nr. ) F APTELE pentru care … · 2015-12-14 · 1 ANEXĂ (Anexa la Hotărârea Guvernului nr. ) F APTELE pentru care se înscriu informaţii

ANEXĂ (Anexa la Hotărârea Guvernului nr. ) F APTELE pentru care … · 2015-12-14 · 1 ANEXĂ (Anexa la Hotărârea Guvernului nr. ) F APTELE pentru care se înscriu informaţii

Documents

The Human CD38 Monoclonal Antibody Daratumumab Shows ... · peripheral blood mononuclear cells to analyze antibody-dependent cell cytotoxicity (ADCC), murine and human macrophages

The Human CD38 Monoclonal Antibody Daratumumab Shows ... · peripheral blood mononuclear cells to analyze antibody-dependent cell cytotoxicity (ADCC), murine and human macrophages

Documents

Dossier zur Nutzenbewertung - g-ba.de · gemäß § Dokumentvorlage, Version vom 18.04.2013 Modul 3 A Janssen-Cilag GmbH Daratumumab als Monotherapie für die Behandlung erwachsener

Dossier zur Nutzenbewertung - g-ba.de · gemäß § Dokumentvorlage, Version vom 18.04.2013 Modul 3 A Janssen-Cilag GmbH Daratumumab als Monotherapie für die Behandlung erwachsener

Documents

daratumumab NEW ZEALAND DATA SHEET - Medsafe · additional symptoms, resume infusion rate escalation at increments and intervals as appropriate (Method of Administration: Table )

daratumumab NEW ZEALAND DATA SHEET - Medsafe · additional symptoms, resume infusion rate escalation at increments and intervals as appropriate (Method of Administration: Table )

Documents

koncentrát na infúzny roztok daratumumab

koncentrát na infúzny roztok daratumumab

Documents

Split First Dose Administration of Intravenous …...intravenous daratumumab for the treatment of multiple myeloma. INTRODUCTION Daratumumab is a human immunoglobulin Gj (IgGj) monoclonal

Split First Dose Administration of Intravenous …...intravenous daratumumab for the treatment of multiple myeloma. INTRODUCTION Daratumumab is a human immunoglobulin Gj (IgGj) monoclonal

Documents

Safety and Efficacy of the Combination of Selinexor, Daratumumab… · 2019-06-14 · Safety and Efficacy of the Combination of Selinexor, Daratumumab, and Dexamethasone (SDd) in

Safety and Efficacy of the Combination of Selinexor, Daratumumab… · 2019-06-14 · Safety and Efficacy of the Combination of Selinexor, Daratumumab, and Dexamethasone (SDd) in

Documents

$Pharmacokinetics of Daratumumab Following …...Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor$

Pharmacokinetics of Daratumumab Following …...Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor

Documents

INDICAȚE: Mielom multiplu TEHNOLOGII MEDICALE/MUTARI... · 2020. 11. 12. · I. Mielom multiplu recent diagnosticat A. Daratumumab în asociere cu bortezomib, melfalan şi prednison

INDICAȚE: Mielom multiplu TEHNOLOGII MEDICALE/MUTARI... · 2020. 11. 12. · I. Mielom multiplu recent diagnosticat A. Daratumumab în asociere cu bortezomib, melfalan şi prednison

Documents

Daratumumab monotherapy for patients with relapsed or

Daratumumab monotherapy for patients with relapsed or

Documents

MONOTHERAPY DOSING & ADMINISTRATION IMPORTANT … · Information on pages 46-49 and click here for DARZALEX® full Prescribing Information. DARZALEX® (daratumumab) + lenalidomide

MONOTHERAPY DOSING & ADMINISTRATION IMPORTANT … · Information on pages 46-49 and click here for DARZALEX® full Prescribing Information. DARZALEX® (daratumumab) + lenalidomide

Documents

0800 980 3332 Daratumumab (Darzalex - Myeloma UK · AskTheNurse@myeloma.org.uk Visit our website at myeloma.org.uk Myeloma UK 22 Logie Mill, Beaverbank Business Park, Edinburgh EH7

0800 980 3332 Daratumumab (Darzalex - Myeloma UK · [email protected] Visit our website at myeloma.org.uk Myeloma UK 22 Logie Mill, Beaverbank Business Park, Edinburgh EH7

Documents

Subcutaneous Delivery of Daratumumab in Patients with

Subcutaneous Delivery of Daratumumab in Patients with

Documents

Daratumumab, A CD38 Monoclonal Antibody in Patients with ...static9.light-kr.com/documents/Plesner - ASH 2012 - Daratumumab.pdf · Daratumumab: GEN501 Phase I/II Study of Monotherapy

Daratumumab, A CD38 Monoclonal Antibody in Patients with ...static9.light-kr.com/documents/Plesner - ASH 2012 - Daratumumab.pdf · Daratumumab: GEN501 Phase I/II Study of Monotherapy

Documents

Multiple Myeloma beyond Daratumumab

Multiple Myeloma beyond Daratumumab

Documents

Monitoring multiple myeloma patients treated with ... multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference DOI 10.1515/cclm-2015-1031 Received

Monitoring multiple myeloma patients treated with ... multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference DOI 10.1515/cclm-2015-1031 Received

Documents